MMJ Recs

DECEMBER 28, 2023

Chronic Pain Relief with Medical Marijuana: How Cannabinoids Ease Discomfort Chronic pain is a pervasive issue affecting millions worldwide, and traditional pain medications may not always offer satisfactory relief. CBD, a non-psychoactive cannabinoid, has gained attention for its anti-anxiety effects.

Conditions 98

Conditions Chronic Pain Epilepsy Research and Development 98

Cannabis Law Report

JULY 8, 2021

Seeks To Identify Novel Cannabinoids For Therapeutic Use. Following the execution of this work, cbdMD Therapeutics will perform the requisite toxicological studies with Ion Tox, a leading in vitro toxicology and ADME-PK testing company, to support the safety of the cannabinoids of interest. CHARLOTTE, N.C.–(BUSINESS

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

MMJ Recs

NOVEMBER 30, 2023

Studies have indicated that certain cannabinoids found in cannabis, particularly CBD, may have anticonvulsant properties. As the field of medical marijuana research continues to evolve, THC’s role in epilepsy management remains a topic of interest and further exploration. Image by Uwe Conrad from Pixabay.

Epilepsy 105

Epilepsy Treatment Patients Strains 105

Cannabis Law Report

JANUARY 19, 2022

With his extensive experience in Congress and as a policy advisor on topics including health, technology, and education, we are confident Congressman Moran will be a great asset to IGC especially at a time when we pursue Phase 2/3 human trials on IGC- AD1 on individuals that have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Education Therapy 52

Medicinal Marijuana Association

FEBRUARY 11, 2024

The potential link between cannabis and glaucoma treatment is a topic of ongoing investigation, stirring both curiosity and caution within the medical community. The anti-inflammatory properties of certain cannabinoids in cannabis could also play a role in protecting retinal cells from damage associated with the condition.

Treatment 52

Treatment Blood Pressure Conditions Clinical Trials 52

The Cannigma

JANUARY 13, 2023

Edibles won’t produce the same experience, but topicals may be able to help, too. The authors noted that while “promising data are emerging on the possible role of ECS in migraine…proper placebo-controlled trials are needed to establish a therapeutic role for cannabinoids.” headaches per month.

Terpenes 132

Terpenes Strains THC Treatment 132

Cannabis Law Report

OCTOBER 22, 2021

Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. Lenabasum is a novel, oral, small molecule that selectively binds as an agonist to the cannabinoid receptor type 2 (CB2) and resolves inflammation and limits fibrosis in animal and human models of disease.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

SEPTEMBER 20, 2021

The products leverage pharmaceutical technology to maximize performance and safety. CB4 products are formulated based on the latest medical evidence and come in convenient dosage forms that deliver effective levels of cannabinoids. Opticann medical cannabis products merge cannabis medicine with modern medicine.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Project CBD

FEBRUARY 28, 2023

sativa do not naturally contain cannabinoids, but they can become contaminated with CBD from other plant parts during processing. The labs analyzed 35 oils, 40 topical products, 40 edibles, 22 beverages, 55 pet products, and 29 coffee or tea products. phosphorus, potassium, and calcium). 2 The seeds of C. PubMed search: “CBD review.”

CBD 144

CBD Seed-To-Sale Food Access 144

Puff Puff Post

NOVEMBER 5, 2019

. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), today announced the filing of a Clinical Trial Application (“CTA”) in the Netherlands to initiate a Phase 1 human clinical trial for INM-755 in healthy volunteers. For more information, visit www.inmedpharma.com. About INM-755.

Clinical Trials 8

Clinical Trials Pharmaceutical Cannabinoids Data 8

The Cannigma

JULY 1, 2022

There’s no doubt that the amount of information that is available about cannabis is at an all-time high – in 2020 alone, over 3,500 scientific articles were published on the topic. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

OCTOBER 18, 2021

Currently, the two main cannabinoids from the marijuana plant that are of medical interest are THC and CBD. Lenabasum is a novel, oral, small molecule that selectively binds as an agonist to the cannabinoid receptor type 2 (CB2) and resolves inflammation and limits fibrosis in animal and human models of disease.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

MAY 29, 2022

Celebrated author Michael Pollan has published two bestselling books on the topic: How to Change Your Mind and This is Your Mind on Plants. Clinical Trials and Human Subject Protections. FDA’s approval of an IND will also require sufficient evidence that the trial will be safe for human subjects. 811(b)–(c). [18]

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

SpeedWeed

MARCH 18, 2021

A fourth group received a placebo with almost zero active cannabinoids. Given the topical nature of the current trial and its relevance for public policy on medical cannabis, participants might have been biased to report positive effects regardless of condition. Another group received an 11% CBD product with minimal THC.

Clinical Trials 40

Clinical Trials THC Strains Cannabis 40

Kind Meds (Cannabis Education Blog)

JANUARY 9, 2019

GW Pharma carefully developed Epidiolex using cannabinoids to reduce the occurrence of seizures. Thanks to their diligence in perfecting the drug and ensuring its safety for intended use, the Drug Enforcement Agency scheduled Epidiolex under the lowest Schedule classification for controlled substances.

Research and Development 97

Research and Development Treatment Pharmaceutical Conditions 97

Cannabis Law Report

OCTOBER 29, 2021

The highlights for the quarter are: As previously disclosed, on September 7, 2021, the Company announced the completion of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”) based investigational new drug, IGC-AD1, intended to alleviate certain symptoms of individuals who have Alzheimer’s disease.

Clinical Trials 52

Clinical Trials Research and Development Data Business 52

Cannabis Law Report

JANUARY 11, 2019

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. CBD has been found to be generally well tolerated with a good safety profile.”.

Hemp 49

Hemp CBD Law Seed-To-Sale 49

The Cannigma

APRIL 8, 2021

Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. Half of those cannabinoids of plant doesn’t make or three quarters because they’re byproducts. This is by nature of the way we consume cannabinoids.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. It was also used as a topical treatment for haemorrhoids, ear infection, and wounds (Aldrich 1997 ; Touw 1981 ).

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

OCTOBER 17, 2019

Retailers such as Walgreens, CVS, Rite Aid, Kroger, Safeway, Nordstrom, and DSW are selling or plan to sell CBD-infused topical lotions, cosmetics, and even edibles where they are legally able to do so. THC is just one of the cannabinoids in the Cannabis sativa L. the form the finished product can take (edibles, topicals, etc.).

Law 40

Law Seed-To-Sale Hemp Recreational 40

Cannabis Law Report

JUNE 11, 2019

Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. A modest award for the cost of Cesamet/Nabilone, the synthetic cannabinoid, was awarded in this case. As a result, the court awarded $6,500.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Harris has written a variety of books that touch on the topics of consciousness, spirituality, and psychedelics. Rick Doblin, Ph.D,

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51